G Gill

1.0k total citations · 1 hit paper
14 papers, 809 citations indexed

About

G Gill is a scholar working on Surgery, Oncology and Epidemiology. According to data from OpenAlex, G Gill has authored 14 papers receiving a total of 809 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 6 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in G Gill's work include Testicular diseases and treatments (4 papers), Global Cancer Incidence and Screening (3 papers) and Breast Cancer Treatment Studies (2 papers). G Gill is often cited by papers focused on Testicular diseases and treatments (4 papers), Global Cancer Incidence and Screening (3 papers) and Breast Cancer Treatment Studies (2 papers). G Gill collaborates with scholars based in Australia, India and United States. G Gill's co-authors include Robert L. Woods, Maureen Byrne, VJ Harvey, Alan S. Coates, Martin H.N. Tattersall, Ray Snyder, James F. Bishop, P. N. Jeal, Val Gebski and John A. Levi and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and British Journal of Cancer.

In The Last Decade

G Gill

14 papers receiving 773 citations

Hit Papers

Improving the Quality of Life during Chemotherapy for Adv... 1987 2026 2000 2013 1987 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Improving the Quality of Life during Chemotherapy for Advanced Breast Cancer
    1987 419 citations Alan S. Coates, Val Gebski et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Gill Australia 8 445 214 181 135 102 14 809
VJ Harvey New Zealand 11 450 1.0× 321 1.5× 160 0.9× 124 0.9× 93 0.9× 16 954
Annette Wigertz Sweden 16 335 0.8× 166 0.8× 216 1.2× 237 1.8× 81 0.8× 19 1.0k
Nuran Beşe Türkiye 19 672 1.5× 196 0.9× 292 1.6× 228 1.7× 115 1.1× 44 1.3k
Hélène Senellart France 19 862 1.9× 293 1.4× 379 2.1× 84 0.6× 53 0.5× 78 1.2k
Antonella Venturino Italy 14 533 1.2× 133 0.6× 279 1.5× 140 1.0× 91 0.9× 57 953
Hikmat Abdel‐Razeq Jordan 17 481 1.1× 118 0.6× 195 1.1× 235 1.7× 52 0.5× 155 1.2k
Vesna Zadnik Slovenia 18 915 2.1× 202 0.9× 331 1.8× 160 1.2× 82 0.8× 56 1.4k
Laurent Cany France 15 709 1.6× 129 0.6× 336 1.9× 143 1.1× 84 0.8× 38 1.2k
Konstantinos Kamposioras Greece 18 570 1.3× 133 0.6× 193 1.1× 111 0.8× 35 0.3× 71 1.0k
Roy Lalisang Netherlands 18 255 0.6× 441 2.1× 232 1.3× 98 0.7× 20 0.2× 51 1.2k

Countries citing papers authored by G Gill

Since Specialization
Citations

This map shows the geographic impact of G Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Gill more than expected).

Fields of papers citing papers by G Gill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Gill. The network helps show where G Gill may publish in the future.

Co-authorship network of co-authors of G Gill

This figure shows the co-authorship network connecting the top 25 collaborators of G Gill. A scholar is included among the top collaborators of G Gill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Gill. G Gill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Buckley, Elizabeth, Gelareh Farshid, G Gill, et al.. (2017). Assessing impact of organised breast screening across small residential areas-development and internal validation of a prediction model. European Journal of Cancer Care. 26(4). e12673–e12673. 5 indexed citations
3.
Zhang, Isabella, G Gill, Amit Sharma, et al.. (2015). Quality of Life and Locoregional Disease Control Following Stereotactic Body Radiation Therapy in Previously Irradiated Recurrent Head and Neck Cancer. International Journal of Radiation Oncology*Biology*Physics. 93(3). S171–S171. 1 indexed citations
4.
Lord, Sarah J., Andrew Martin, G Gill, et al.. (2012). Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysis. British Journal of Cancer. 106(6). 1045–1052. 34 indexed citations
5.
Borg, Matthew, Eric Yeoh, Melissa Bochner, et al.. (2007). Feasibility study on the MammoSite in early‐stage breast cancer: Initial experience. Australasian Radiology. 51(1). 53–61. 3 indexed citations
6.
Roder, David, Gelareh Farshid, G Gill, et al.. (2007). Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia. Breast Cancer Research and Treatment. 108(3). 409–416. 97 indexed citations
7.
Nowak, Anna K., Carolyn Hargreaves, G Gill, et al.. (2004). Health-related quality of life (HRQL) before and 1 month after axillary surgery in a randomized trial of sentinel node (SN) biopsy versus axillary clearance (AC): the SNAC Trial.. Breast Cancer Research and Treatment. 88. 2 indexed citations
8.
Levi, J.A., Derek Raghavan, VJ Harvey, et al.. (1993). The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. Australasian Germ Cell Trial Group.. Journal of Clinical Oncology. 11(7). 1300–1305. 102 indexed citations
9.
Levi, John A., Damien Thomson, V. Harvey, et al.. (1990). Effective salvage chemotherapy with etoposide, dactinomycin, and methotrexate in refractory germ cell cancer. Australasian Germ Cell Trial Group.. Journal of Clinical Oncology. 8(1). 27–32. 15 indexed citations
10.
Levi, John A., Damien Thomson, Martin Tattersall, et al.. (1988). A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up.. Journal of Clinical Oncology. 6(7). 1154–1160. 48 indexed citations
11.
Coates, Alan S., Val Gebski, James F. Bishop, et al.. (1987). Improving the Quality of Life during Chemotherapy for Advanced Breast Cancer. New England Journal of Medicine. 317(24). 1490–1495. 419 indexed citations breakdown →
12.
Harvey, John A. Levi, Derek Raghavan, et al.. (1986). Deletion of Bleomycin From Therapy for Good Prognosis Advanced Testicular Cancer - a Prospective Randomized Study. New Zealand medical journal. 99(811). 769–769. 13 indexed citations
13.
14.
Gill, G & David C. Rice. (1975). Radiation effects on microbiological flora of patients with head and neck cancer.. PubMed. 26. 533–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by VJ Harvey Breakdown of academic impact, for papers by Annette Wigertz Breakdown of academic impact, for papers by Nuran Beşe Breakdown of academic impact, for papers by Hélène Senellart Breakdown of academic impact, for papers by Antonella Venturino Breakdown of academic impact, for papers by Hikmat Abdel‐Razeq Breakdown of academic impact, for papers by Vesna Zadnik Breakdown of academic impact, for papers by Laurent Cany Breakdown of academic impact, for papers by Konstantinos Kamposioras Breakdown of academic impact, for papers by Roy Lalisang
Rankless by CCL
2026